ALLMedicine™ Microcystic Adnexal Carcinoma Center
Research & Reviews 60 results
World Journal of Surgical Oncology; Yu S, Wang Y et. al.
May 6th, 2022 - Microcystic adnexal carcinoma (MAC) is a skin cancer with challenges in diagnosis and management. This study was aimed to detect molecular alterations of MAC and guide its pathologic diagnosis and treatment. We performed transcriptome analysis on ...
Applied Immunohistochemistry & Molecular Morphology : AIMM; Mohanty SK, Sardana R et. al.
Apr 7th, 2022 - The distinction among cutaneous basaloid neoplasms such as trichoepithelioma (TE), desmoplastic trichoepithelioma (DTE), morpheaform basal cell carcinoma (MBCC), and microcystic adnexal carcinoma (MAC) can be difficult, especially in superficial b...
European Journal of Cancer (Oxford, England : 1990); Battistella M, Balme B et. al.
Jan 30th, 2022 - To prospectively assess the impact of expert pathological review of skin adnexal carcinoma diagnosis in France. From 2014 to 2019, 2573 samples from patients with newly diagnosed or suspected skin adnexal carcinomas were reviewed prospectively by ...
Clinical and Experimental Dermatology; Charalambides M, Yannoulias B et. al.
Dec 24th, 2021 - Mohs micrographic surgery (MMS) is a precise and effective method commonly used to treat high-risk basal cell carcinoma and squamous cell carcinoma on the head and neck. Although the majority of evidence for MMS relates to keratinocyte cancers, th...
Cancer Treatment Reviews; Garcia A, Nelson K et. al.
Aug 22nd, 2021 - Rare cutaneous cancers require early management given their aggressive nature; however, few therapeutic options exist for managing these rare cancers. To identify emerging therapies for extramammary Paget's disease, Merkel cell carcinoma, sebaceou...
News 5 results
Steven A. Svoboda, MD, Patrick S. Rush, DO et. al.
Jun 16th, 2021 - Squamoid eccrine ductal carcinoma (SEDC) is an aggressive underrecognized cutaneous malignancy of unknown etiology. 1 It is most likely to occur in sun-exposed areas of the body, most commonly the head and neck.
Hu JC, Ko CJ et. al.
Jan 1st, 2006 - Syringomatous carcinoma (SC), considered by some to be a variant of microcystic adnexal carcinoma (MAC),1 is a rare malignant neoplasm of sweat gland origin. SC encompasses a range of neoplasms with different degrees of differentiation, and its no.
Page RN, Hanggi MC et. al.
Microcystic adnexal carcinoma (MAC) is a relatively uncommon adnexal neoplasm that can demonstrate locally aggressive behavior; rare instances of metastatic lesions have been reported. We report a case of a 34-year-old black man with multiple prim.
SAN DIEGO Tumors travel within the nerve structure, so if a Mohs surgeon has a habit of taking superficial margins, he or she will miss perineural tumors, Dr. Alexander Miller said at a meeting sponsored by the American Society for Mohs Surgery.
Carcinogenesis While in vitro PDT may have cytotoxic and genotoxic effects,[182,183] the porphyrin-derived molecules used in topical PDT can also have both antioxidant and antimutagenic actions. In hairless mouse models, both MAL-PDT and hexy...